Table 3.
Ordinal logistic regression modeling of COVID-19 severity versus significantly associated variables.
| Patient variables |
Disease severity |
|||
|---|---|---|---|---|
| All (n = 275) n (%) | Hazard ratio (CI) | P-value | ||
| ICS use | Reference: ICS users | 0.37 (−0.36,1.12) | 0.317 | |
| Combo (ICS + LABA) vs. Mono (ICS only) | Budesonide/Formoterol | 135 (49.1) | 3.9 (2.3, 5.4) | <0.001* |
| OR | ||||
| Fluticasone/salmeterol combinations (reference: no ICS/LABA) | ||||
| Comorbidities | Hypertension (reference: no hypertension) | 64 (23.3) | 0.72 (0.15, 1.2) | 0.021* |
| Malignancy (reference: no malignancy) | 8 (2.9) | 0.98 (0.28, 1.6) | 0.006* | |
| Diabetes (reference: no diabetes) | 72 (26.2) | 1.49 (0.12, 2.8) | 0.033* | |
*
Significant.